Cite
HARVARD Citation
Shock, A. et al. (2015). CDP7657, an anti-CD40L antibody lacking an Fc domain, inhibits CD40L-dependent immune responses without thrombotic complications: an in vivo study. Arthritis research & therapy. 17 (1), pp. 1-12. [Online].